News & Articles

Funding will advance 3D lung cell culture models to accelerate drug discovery

The adjustable tip spacing pipettes from INTEGRA are used to increase efficiency in the production of venom-based screening assays

This effort will study virus variants in the UK and South Africa and what that means for the transmission of SARS-CoV-2

The research helps shed light on genes responsible for a shield-like capsule that could help protect some bacteria from our immune system, making them deadly

Discover how AFABILITY founder Dr. Alison Gray is enabling the transition from animal-derived to non-animal-derived antibodies

AstraZeneca anticipates entering clinical development in 2021

Connecting the scientific community with two new online content-packed events

Interim data shows strong antibody and T-cell responses in all evaluated participants

Collaboration combines innovative plant-based and adjuvant technologies to develop and produce a COVID-19 candidate vaccine

Key topics to include COVID-19 and infectious diseases, diabetes, sepsis, cardiovascular disease and personalized medicine as the global clinical community comes together to make the future healthier

LifeShare Blood Center deploys Biolog-id’s cutting-edge technology providing digital visibility to convalescent plasma containing antibodies from recovered COVID-19 patients

Our expert webinar series aims to help you get the most from your drug discovery research

Total antibody test aims to deliver superior clinical performance with 100% sensitivity and 99.8% specificity

Dr. Sylvia Boj discusses the advantages of organoids and how these 3D tissue cultures have enormous potential to revolutionize how we treat patients and predict therapeutic response

Register for free today to discover the latest science and technology advancements in coronavirus research, CAR T-cell therapy, genomics, liquid biopsies, imaging, drug delivery mechanisms, microbiome research and more

Explore a compilation of some of the most innovative technology news relating to the novel coronavirus and the COVID-19 disease

The team at the University of Edinburgh believe new therapies could be discovered before a vaccine becomes available

The strategic partnership with Australian National Phenome Centre (ANPC) aims to support the work of their researchers

The rapid delivery program is designed to provide critical laboratory equipment in this time of need

This critical appeal was made to the life sciences sector in order to tackle the spread of coronavirus

Chairman and CEO Albert Bourla calls on biopharma industry to collaborate on combating the global pandemic

Harvard, MIT, and various teaching hospitals team up with industry partners to launch new center for regenerative therapies

Newly discovered antibodies promise significant improvement over current therapies

Envigo enters CRISPR gene-edited research model field with the addition of Horizon’s business